Dequilla, Jesus M.

HRN: 18-20-27  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/23/2023
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
02/23/2023
03/01/2023
IV
4.5g
TID
CAP HR
Waiting Final Action 
03/01/2023
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
03/01/2023
03/14/2023
IV
2.25g
Q8
CAP HR (Antibiotic Extension)
Waiting Final Action 
03/01/2023
LEVOFLOXACIN 500MG (TAB)
03/01/2023
03/07/2023
NGT
750mg
OD
CAP HR (Antibiotic Extension)
Waiting Final Action 
03/04/2023
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
03/02/2023
03/10/2023
IV
2.25g
Q6
CAP HR (Revised Order From Q8)
Waiting Final Action 
03/05/2023
LEVOFLOXACIN 5MG/ML, 100ML (VIAL)
03/05/2023
03/08/2023
IV
500mg
OD
CAP HR (shift From Oral To IV)
Waiting Final Action 
03/05/2023
LEVOFLOXACIN 5MG/ML, 100ML (VIAL)
03/06/2023
03/08/2023
IV
500mg
OD
CAP HR (Shift From Oral To IV For 3 More Days)
Waiting Final Action 
03/05/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
03/05/2023
03/11/2023
IV
500mg
Q6
CAP HR
Waiting Final Action 
03/08/2023
CEFTAZIDIME 1GM (VIAL)
03/08/2023
03/14/2023
IV
1g
Q8h
CAP HR
Waiting Final Action 
03/21/2023
CLINDAMYCIN 150MG/ML, 4ML (AMP)
03/21/2023
03/27/2023
IVT
600mg
Q8
Pneumonia, Unaerobic Coverage
Waiting Final Action 
03/23/2023
CO-AMOXICLAV 625MG (TAB)
03/23/2023
03/29/2023
PO
625mgtab
Q8
Pneumonia
Waiting Final Action 
03/28/2023
MUPIROCIN 2%, 15G (TUBE)
03/28/2023
04/03/2023
TOPICAL
Depends
Bid
Infected Wounds
Waiting Final Action 
04/22/2023
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
04/22/2023
04/28/2023
IVT
4.5g
Q6
Sepsis
Waiting Final Action 
05/02/2023
METRONIDAZOLE 500MG (TAB)
05/02/2023
05/11/2023
NGT
500mg
TID
Sepsis, FOBT Positive
Waiting Final Action 
05/02/2023
CIPROFLOXACIN 500MG (TAB)
05/02/2023
05/11/2023
NGT
500mg
BID
UTI
Waiting Final Action 
05/04/2023
AMOXICILLIN 500MG CAPSULE (CAP)
05/04/2023
05/10/2023
NGT
500mg
TID
CAP HR, Sepsis
Waiting Final Action 
02/14/2023
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
05/18/2023
05/25/2023
IV
600mg
OD
Cathether Associated UTI
Checking Final Appropriateness 
05/19/2023
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
05/19/2023
05/26/2023
IV
600mg
OD
Complicated UTI
Waiting Final Action 
06/10/2023
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
06/10/2023
06/17/2023
IV
4.5g
Q8
CAP MR

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: